|
- 积分
- 279
- 威望
- 279
- 包包
- 128
|
Title: CD133: molecule of the moment.
5 A: j! \ z# t+ z5 f4 X; R+ v7 uAuthor: Mizrak, D.; Brittan, M.; Alison, M. R.
) `# C& Q/ j! J2 `Source: J Pathol, 2008, 214(1): 3-93 R: t# W! ]/ o: m, @: k/ ~! M# R
% p2 U6 @7 V! ]Title: Focus on molecules: prominin-1 (CD133).
" X9 B! p, z$ ~Author: Jaszai, J.; Fargeas, C. A.; Florek, M. (...)
2 {# P+ H0 v Z) _1 _Source: Exp Eye Res, 2007, 85(5): 585-586
$ z0 ?1 i/ U9 \( O% i" Y0 r$ P0 U8 h5 a/ G0 C5 u+ a v
Title: CD133.
: h" R/ K- A' N; zAuthor: Piechaczek, C.% K" a; ?7 F+ j9 J* k% {
Source: J Biol Regul Homeost Agents, 2001, 15(1): 101-102
! Y, G- U2 q! ^' T& ^0 M& I# A- |! H* H9 z/ {- R% `, W
Title: CD133 as a marker for cancer stem cells: progresses and concerns.
0 k8 \% F; f& d7 I# [Author: Wu, Y.; Wu, P. Y.' ~. ?, d4 c! S
Source: Stem Cells Dev, 2009, 18(8): 1127-11342 Q9 D9 p A) N J5 k) |5 n! L* w8 R
1 V( m. |5 ] MTitle: Risk and benefit of CD133+ progenitors.
, n4 z$ R3 _& J* W. |! c/ [Author: Ascione, R.; Madeddu, P.
1 Z5 @% X1 W- @/ l; @Source: Circ Res, 2009, 105(2): e2' h8 Y0 S9 D/ W( W7 M I9 S+ S
3 J: C c5 N* }" U: [Title: Targeting CD133 antigen in cancer.
* d3 i6 ^. Q; |) n6 `; GAuthor: Ferrandina, G.; Petrillo, M.; Bonanno, G. (...)6 i% y0 k# U' N
Source: Expert Opin Ther Targets, 2009, 13(7): 823-837: m3 A9 r, s. C( j. J0 X' j
6 e5 g8 l5 y5 A- I3 N1 X% ?' g
Title: Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.
; K$ j4 H3 Q" N( I, _* z4 n" HAuthor: Ogden, A. T.; Waziri, A. E.; Lochhead, R. A. (...)0 g, V. k, U9 d, b _# x
Source: Neurosurgery, 2008, 62(2): 505-514, 514-515 |
|
发表于 2010-7-9 14:12
发表于 2010-7-9 22:47
rogresses and Concerns不好意思，没看到楼上的已经发了这一篇